News

Salk Institute’s Christina Towers recognized for scientific achievements and dedication to diversity, equity, and inclusion

LA JOLLA—Salk Institute Assistant Professor Christina Towers has received a $1.15 million Science Diversity Leadership Award from the Chan Zuckerberg Initiative, in partnership with the National Academies of Sciences, Engineering, and Medicine. The award recognizes […]

No Picture
News

OncoK9®, the Pioneering Blood-Based Early Cancer Detection Test for Dogs, Now Available in Asia Through Asia Veterinary Diagnostics

In the first expansion of access beyond North America, the OncoK9® test from PetDx® is now available in Hong Kong, Singapore, Malaysia, South Korea, and Cambodia at veterinary clinics served by Asia Veterinary Diagnostics. SAN […]

No Picture
News

Surglogs is SOC 2 Type II Compliant

Surglogs protects customer data in accordance with the strictest security, availability, confidentiality, and privacy standards. SAN DIEGO, Oct. 26, 2022 /PRNewswire/ — Committed to providing the highest levels of information security for its customers, Surglogs, […]

No Picture
News

Equillium Announces Presentation of Data Demonstrating Biological Importance of Multi-Cytokine Inhibitors EQ101 and EQ102 at the La Jolla Immunology Conference

LA JOLLA, Calif.–(BUSINESS WIRE)—- $EQ–Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need, today announced data presented at the […]

No Picture
News

Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

SAN DIEGO–(BUSINESS WIRE)–Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) Click here to view original post

News

Origin Story

An uncanny number of speculative fiction writers have roots at UC San Diego. Author Sarina Dahlan ’98 explores this phenomenon with other alumni writers. Click here to view original post

No Picture
News

Inipharm to Present Data on Anti-Fibrotic Effects of Its Development Candidate Targeting HSD17B13 at AASLD’s The Liver Meeting

BELLEVUE, Wash. & SAN DIEGO–(BUSINESS WIRE)–Inipharm, a biopharmaceutical company focused on discovering and developing therapies for severe liver diseases, today announced that data on its development candidate INI-822, an inhibitor of HSD17B13, will be presented […]

News

Trailblazing Immunologist joins Salk faculty to study mother-baby immunity during pregnancy and breastfeeding

LA JOLLA—The Salk Institute welcomes Assistant Professor Deepshika Ramanan, an innovative researcher studying how the maternal immune system changes during pregnancy and breastfeeding and affects immunity and inflammation in babies across multiple generations. Ramanan will […]

No Picture
News

SHORELINE BIOSCIENCES ANNOUNCES APPOINTMENT OF CELL THERAPY MANUFACTURING VETERAN CHARLES CALDERARO III AS CHIEF TECHNICAL OFFICER

SAN DIEGO, Oct. 24, 2022 /PRNewswire/ — Shoreline Biosciences, Inc. (Shoreline), a biopharmaceutical company developing next-generation cellular immunotherapies based on induced pluripotent stem cells (iPSCs) utilizing its proprietary iPSC-derived natural killer (iNK) cell and macrophage… […]

News

FUJIFILM Diosynth Biotechnologies and RoosterBio Announce Collaboration to enable GMP Manufacturing of Cell and Exosome Therapies

College Station, Texas, October 24 2022 — FUJIFILM Diosynth Biotechnologies, a world leading contract development and manufacturing organization (CDMO) for biologics, vaccines, and advanced therapies, announced today a strategic collaboration with RoosterBio, Inc. , a leading […]